Phase 2 Celiac Disease Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Study of DONQ52 in Active Celiac Disease
Celiac Disease
Chugai Pharmaceutical92 enrolled38 locationsNCT07239336
Recruiting
Phase 2
Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease
Celiac Disease
Dr. Falk Pharma GmbH356 enrolled1 locationNCT07298343
Recruiting
Phase 2
A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
Celiac Disease
Teva Branded Pharmaceutical Products R&D LLC48 enrolled21 locationsNCT06807463
Recruiting
Phase 2
Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease
Celiac Disease
Forte Biosciences, Inc.100 enrolled1 locationNCT06982963
Recruiting
Phase 2
Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission
Celiac Disease
Massachusetts General Hospital40 enrolled1 locationNCT05636293